NexGel, Inc. Receives Nasdaq Minimum Bid Price Deficiency Notice – Shareholder Implications and Next Steps

NexGel, Inc. (NASDAQ: NXGL) has disclosed in its latest SEC filing that it received a deficiency letter from the Nasdaq Listing Qualifications Department on April 22, 2026. The notice was issued because the closing bid price for the company’s common stock has remained below the \$1.00 per share minimum required for continued listing on The Nasdaq Capital Market for the previous 30 consecutive business days.

Key Points from the Report

• Nasdaq Minimum Bid Price Deficiency: The company’s stock has traded below \$1.00 per share for 30 consecutive business days, triggering a notice from the Nasdaq Listing Qualifications Department under Nasdaq Listing Rule 5550(a)(2), also known as the Minimum Bid Price Requirement.
• Immediate Listing Status Unchanged: Despite the deficiency notice, NexGel’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “NXGL” at this time.
• Potential Compliance Actions: The company is actively monitoring its share price and is considering available options to regain compliance. These may include a reverse stock split, though no firm decision has been made and there is no assurance that compliance will be regained.
• Ongoing Nasdaq Rule Compliance: There is also no guarantee the company will remain compliant with other listing rules in the future.

Important Shareholder Information

• Share Value at Risk: The Nasdaq notice itself does not immediately affect the listing or trading of NXGL shares, but if the company fails to regain compliance, its shares could ultimately be delisted. Delisting could significantly reduce liquidity and may have a negative impact on share price.
• Potential Reverse Stock Split: Management has indicated that a reverse stock split is one of the options being considered to restore compliance with Nasdaq’s minimum bid price rule. A reverse split, if implemented, could affect the number of outstanding shares and the trading price, impacting both existing shareholders and prospective investors.
• Market Perception and Volatility: The deficiency notice can sometimes create negative sentiment in the market, potentially leading to increased share price volatility. Investors should be aware of possible short-term fluctuations and longer-term risks if compliance is not restored.
• Emerging Growth Company Status: The filing confirms that NexGel continues to qualify as an “emerging growth company,” which may provide certain regulatory and reporting advantages.
• No Immediate Changes to Warrants: NexGel also has warrants to purchase common stock (trading under the symbol “NXGLW”), which continue to be listed on the Nasdaq Capital Market.

What Should Shareholders Do?

• Monitor Company Announcements: Shareholders should closely follow NexGel’s press releases and SEC filings for updates regarding any compliance actions, including the potential for a reverse stock split.
• Be Aware of Delisting Risk: Should NexGel fail to regain compliance within the timeframe provided by Nasdaq (typically 180 calendar days, subject to certain conditions), the company’s shares may be subject to delisting.
• Understand the Implications of a Reverse Split: If a reverse stock split is executed, shareholders’ number of shares will decrease, but the market price per share should increase proportionally. This move aims to bring the share price back above \$1.00, in compliance with Nasdaq rules.

Conclusion

The Nasdaq deficiency notice is a significant development for NexGel and its shareholders. While the company has time and options to regain compliance, the risk of delisting, share price volatility, and the prospect of a reverse stock split are all factors that could impact current and prospective investors. It is essential for shareholders to stay informed and consider potential outcomes as the company works to address the issue.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with a financial advisor before making investment decisions. The information herein is based on the company’s SEC filings and may be subject to change as new information becomes available.

View NEXGEL, INC. Historical chart here